Helicobacter pylori is a gram-negative, aerobic bacteria that maintains the stomach ecology. Although these bacteria are beneficial to the human health, they can cause infection to the stomach lining. The bacterium can also act as causative agents for gastritis and gastric ulcers, stomach cancer, small intestine infections, and duodenal ulcers. This has led to an increase in the requirement for diagnostic techniques that could be used to identify the presence of Helicobacter pylori infection. In the case of positive diagnosis of ulcers caused due to this bacteria, the patient is subjected to a treatment regimen including antibiotic therapy for 10-14 days. This treatment regimen could include a combination of one or two antibiotics such as amoxicillin, metronidazole, tetracycline, or clarithromycin with bismuth subsalicylate, ranitidine bismuth citrate, and a proton pump inhibitor.
Growth in cost-effectiveness of diagnosis and demand for personalized antibiotic therapy drive the market growth. The availability of cost-effective antibiotics and shorter duration of treatment are expected to increase the adoption of antibiotic regimen, which in turn will boost the demand for pre- and post-monitoring tests. Moreover, the increase in the incidence of Helicobacter pylori infection, rise in demand for early detection of symptoms, and advancement in the diagnostic techniques further fuel the market. . However, competitive pricing pressure due to presence of highly competitive market players may hinder the market growth.
The global helicobacter pylori diagnostics market is segmented based on technology, end user, and geography. Based on technology, it is categorized into immunoassays, point of care (POC), and molecular diagnostics. Based on end user, it is further divided into hospitals & clinics, diagnostic laboratories, and physicians' offices. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of market players, such as Thermo Fisher Scientific, Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Biohit, Meridian Bioscience, Certest Biotec, Quest Diagnostics, Coris BioConcept, and Epitope Diagnostics are also provided in this report.
- This report provides an extensive analysis of the current and emerging market trends and dynamics through 2017-2023 in the global helicobacter pylori diagnostics market to identify the prevailing market opportunities.
- The projections in this report are made by analyzing the current trends and future market potential from 2017 to 2023, in terms of value.
- Competitive intelligence helps to understand the competitive scenario across the geographies.
- An in-depth analysis of current research and clinical developments within market is provided with key dynamic factors that help understand the market behavior.
Helicobacter Pylori Diagnostics Market Key Segments:
- Molecular Diagnostics
By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Physicians' Offices
"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA